
European Journal of Medicinal Chemistry p. 399 - 420 (1998)
Update date:2022-08-05
Topics:
Leonardi, Amedeo
Motta, Gianni
Pennini, Renzo
Testa, Rodolfo
Sironi, Giorgio
Catto, Alberto
Cerri, Alberto
Zappa, Marco
Bianchi, Giorgio
Nardi, Dante
A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenylpropylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4- dihydropyridines binding site labelled by 3H-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375- lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries.
View MoreHANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
Suzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
suzhou chukai pharmateach co,.ltd
Contact:86-512-88812511
Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
Contact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Doi:10.1007/s11178-006-0034-8
(2005)Doi:10.1021/jm00117a013
(1988)Doi:10.1016/0022-328X(85)80069-3
(1985)Doi:10.1016/j.bmc.2007.11.060
(2008)Doi:10.1016/S0040-4020(01)96638-4
(1985)Doi:10.1021/jm901771h
(2010)